{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:39:28Z","timestamp":1793320768096,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["111-2320-B-006-035-MY3 and 111-2320-B-006-020-MY3"],"award-info":[{"award-number":["111-2320-B-006-035-MY3 and 111-2320-B-006-020-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biosci"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Aggregation of misfolded mutant Huntingtin (mHTT) is a pathological characteristic in Huntington\u2019s disease (HD), implying clearance of mHTT is a therapeutical direction for this neurodegenerative disorder. Based on previous studies, Insulin-like growth factor 2 (IGF2) enhances microfilament polymerization in HD models; however, the role of IGF2 against mHTT aggregates is still unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Here, we demonstrate that IGF2 expression is significantly lower in symptomatic HD patients compared to presymptomatic individuals, and IGF2 activation mechanistically enhances phosphorylation of Protein Kinase B(AKT; serine\/threonine kinase), which subsequently reduces mHTT aggregates in vitro. Furthermore, IGF2 stimulates Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-\u03baB) signaling, promoting the secretion of mHTT within extracellular vesicles, thereby aiding cellular clearance. In vivo studies in R6\/2 HD transgenic mice reveal that IGF2 administration improves motor functions and decreases mHTT levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Collectively, our findings elucidate the multifaceted role of IGF2 in HD, highlighting its therapeutic potential through modulation of AKT and NF-\u03baB signaling pathways.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13578-025-01452-4","type":"journal-article","created":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T11:23:59Z","timestamp":1753529039000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Insulin-like growth factor 2 reduces Huntington\u2019s disease aggregates via AKT and NF-\u03baB signaling in huntington\u2019s disease"],"prefix":"10.1186","volume":"15","author":[{"given":"Yun-Shiuan","family":"Tung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Wei","family":"Tung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siew Chin","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ching","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Ming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Hsun","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan-Mu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1601-3653","authenticated-orcid":false,"given":"Shang-Hsun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,26]]},"reference":[{"issue":"1","key":"1452_CR1","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12929-021-00755-1","volume":"28","author":"CW Tung","year":"2021","unstructured":"Tung CW, Huang PY, Chan SC, Cheng PH, Yang SH. The regulatory roles of MicroRNAs toward pathogenesis and treatments in huntington\u2019s disease. J Biomed Sci. 2021;28(1):59.","journal-title":"J Biomed Sci"},{"key":"1452_CR2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/7854_2010_105","volume":"7","author":"SH Yang","year":"2011","unstructured":"Yang SH, Chan AW. Transgenic animal models of huntington\u2019s disease. Curr Top Behav Neurosci. 2011;7:61\u201385.","journal-title":"Curr Top Behav Neurosci"},{"issue":"1","key":"1452_CR3","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ymeth.2009.05.007","volume":"49","author":"AW Chan","year":"2009","unstructured":"Chan AW, Yang SH. Generation of Transgenic monkeys with human inherited genetic disease. Methods (San Diego Calif). 2009;49(1):78\u201384.","journal-title":"Methods (San Diego Calif)"},{"issue":"Pt 2","key":"1452_CR4","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.freeradbiomed.2023.10.407","volume":"209","author":"SC Chan","year":"2023","unstructured":"Chan SC, Tung CW, Lin CW, Tung YS, Wu PM, Cheng PH, et al. miR-196a provides antioxidative neuroprotection via USP15\/Nrf2 regulation in huntington\u2019s disease. Free Radic Biol Med. 2023;209(Pt 2):292\u2013300.","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"1452_CR5","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1159\/000491889","volume":"48","author":"IO Yusuf","year":"2018","unstructured":"Yusuf IO, Cheng PH, Chen HM, Chang YF, Chang CY, Yang HI, et al. Fibroblast growth factor 9 suppresses striatal cell death dominantly through ERK signaling in huntington\u2019s disease. Cell Physiol Biochem. 2018;48(2):605\u201317.","journal-title":"Cell Physiol Biochem"},{"issue":"4","key":"1452_CR6","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/bpa.12191","volume":"25","author":"LS Her","year":"2015","unstructured":"Her LS, Lin JY, Fu MH, Chang YF, Li CL, Tang TY, et al. The differential profiling of Ubiquitin-Proteasome and autophagy systems in different tissues before the onset of huntington\u2019s disease models. Brain Pathol. 2015;25(4):481\u201390.","journal-title":"Brain Pathol"},{"issue":"1","key":"1452_CR7","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00429-012-0401-x","volume":"218","author":"PH Cheng","year":"2013","unstructured":"Cheng PH, Li CL, Her LS, Chang YF, Chan AW, Chen CM, et al. Significantly differential diffusion of neuropathological aggregates in the brain of Transgenic mice carrying N-terminal mutant Huntingtin fused with green fluorescent protein. Brain Struct Function. 2013;218(1):283\u201394.","journal-title":"Brain Struct Function"},{"issue":"2","key":"1452_CR8","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.ajhg.2013.05.025","volume":"93","author":"PH Cheng","year":"2013","unstructured":"Cheng PH, Li CL, Chang YF, Tsai SJ, Lai YY, Chan AW, et al. miR-196a ameliorates phenotypes of huntington disease in cell, Transgenic mouse, and induced pluripotent stem cell models. Am J Hum Genet. 2013;93(2):306\u201312.","journal-title":"Am J Hum Genet"},{"key":"1452_CR9","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.omtn.2022.10.002","volume":"30","author":"HI Yang","year":"2022","unstructured":"Yang HI, Huang PY, Chan SC, Tung CW, Cheng PH, Chen CM, et al. miR-196a enhances polymerization of neuronal microfilaments through suppressing IMP3 and upregulating IGF2 in huntington\u2019s disease. Mol Ther Nucleic Acids. 2022;30:286\u201399.","journal-title":"Mol Ther Nucleic Acids"},{"key":"1452_CR10","doi-asserted-by":"crossref","unstructured":"Blyth AJ, Kirk NS, Forbes BE. Understanding IGF-II action through insights into receptor binding and activation. Cells. 2020;9(10).","DOI":"10.3390\/cells9102276"},{"issue":"6270","key":"1452_CR11","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/345078a0","volume":"345","author":"TM DeChiara","year":"1990","unstructured":"DeChiara TM, Efstratiadis A, Robertson EJ. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature. 1990;345(6270):78\u201380.","journal-title":"Nature"},{"issue":"Suppl 3","key":"1452_CR12","first-page":"50","volume":"65","author":"AL Fowden","year":"2006","unstructured":"Fowden AL, Sibley C, Reik W, Constancia M. Imprinted genes, placental development and fetal growth. Horm Res. 2006;65(Suppl 3):50\u20138.","journal-title":"Horm Res"},{"issue":"7","key":"1452_CR13","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1042\/CS20210128","volume":"135","author":"Y Zhu","year":"2021","unstructured":"Zhu Y, Gui W, Tan B, Du Y, Zhou J, Wu F, et al. IGF2 deficiency causes mitochondrial defects in skeletal muscle. Clin Sci (Lond). 2021;135(7):979\u201390.","journal-title":"Clin Sci (Lond)"},{"issue":"2","key":"1452_CR14","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.cytogfr.2008.01.005","volume":"19","author":"W Chao","year":"2008","unstructured":"Chao W, D\u2019Amore PA. IGF2: epigenetic regulation and role in development and disease. Cytokine Growth Factor Rev. 2008;19(2):111\u201320.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"6","key":"1452_CR15","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.tins.2023.03.007","volume":"46","author":"CM Alberini","year":"2023","unstructured":"Alberini CM. IGF2 in memory, neurodevelopmental disorders, and neurodegenerative diseases. Trends Neurosci. 2023;46(6):488\u2013502.","journal-title":"Trends Neurosci"},{"issue":"10","key":"1452_CR16","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1101\/lm.029348.112","volume":"21","author":"SA Stern","year":"2014","unstructured":"Stern SA, Chen DY, Alberini CM. The effect of insulin and insulin-like growth factors on hippocampus- and amygdala-dependent long-term memory formation. Learn Mem. 2014;21(10):556\u201363.","journal-title":"Learn Mem"},{"issue":"10","key":"1452_CR17","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.15252\/emmm.201404228","volume":"6","author":"M Pascual-Lucas","year":"2014","unstructured":"Pascual-Lucas M, Viana da Silva S, Di Scala M, Garcia-Barroso C, Gonz\u00e1lez-Aseguinolaza G, Mulle C, et al. Insulin-like growth factor 2 reverses memory and synaptic deficits in APP Transgenic mice. EMBO Mol Med. 2014;6(10):1246\u201362.","journal-title":"EMBO Mol Med"},{"issue":"1","key":"1452_CR18","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/s41420-023-01734-1","volume":"9","author":"J Arcos","year":"2023","unstructured":"Arcos J, Grunenwald F, Sepulveda D, Jerez C, Urbina V, Huerta T, et al. IGF2 prevents dopaminergic neuronal loss and decreases intracellular alpha-synuclein accumulation in parkinson\u2019s disease models. Cell Death Discov. 2023;9(1):438.","journal-title":"Cell Death Discov"},{"issue":"6","key":"1452_CR19","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.3892\/etm.2016.3210","volume":"11","author":"Y Chen","year":"2016","unstructured":"Chen Y, Liu XH, Wu JJ, Ren HM, Wang J, Ding ZT, et al. Proteomic analysis of cerebrospinal fluid in amyotrophic lateral sclerosis. Exp Ther Med. 2016;11(6):2095\u2013106.","journal-title":"Exp Ther Med"},{"key":"1452_CR20","doi-asserted-by":"publisher","first-page":"25960","DOI":"10.1038\/srep25960","volume":"6","author":"I Allodi","year":"2016","unstructured":"Allodi I, Comley L, Nichterwitz S, Nizzardo M, Simone C, Benitez JA, et al. Differential neuronal vulnerability identifies IGF-2 as a protective factor in ALS. Sci Rep. 2016;6:25960.","journal-title":"Sci Rep"},{"issue":"7","key":"1452_CR21","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","volume":"129","author":"BD Manning","year":"2007","unstructured":"Manning BD, Cantley LC. AKT\/PKB signaling: navigating downstream. Cell. 2007;129(7):1261\u201374.","journal-title":"Cell"},{"issue":"1","key":"1452_CR22","first-page":"19","volume":"2","author":"Y Liao","year":"2010","unstructured":"Liao Y, Hung MC. Physiological regulation of Akt activity and stability. Am J Transl Res. 2010;2(1):19\u201342.","journal-title":"Am J Transl Res"},{"key":"1452_CR23","doi-asserted-by":"publisher","first-page":"116444","DOI":"10.1016\/j.lfs.2019.04.070","volume":"254","author":"Y Liu","year":"2020","unstructured":"Liu Y, Wang H, Liu N, Du J, Lan X, Qi X, et al. Oxymatrine protects neonatal rat against hypoxic-ischemic brain damage via PI3K\/Akt\/GSK3beta pathway. Life Sci. 2020;254:116444.","journal-title":"Life Sci"},{"key":"1452_CR24","doi-asserted-by":"crossref","unstructured":"Li L, Lin Z, Yuan J, Li P, Wang Q, Cho N et al. The neuroprotective mechanisms of naringenin: Inhibition of apoptosis through the PI3K\/AKT pathway after hypoxic-ischemic brain damage. J Ethnopharmacol. 2024;318(Pt A):116941.","DOI":"10.1016\/j.jep.2023.116941"},{"key":"1452_CR25","doi-asserted-by":"publisher","first-page":"642415","DOI":"10.3389\/fphar.2021.642415","volume":"12","author":"W Wei","year":"2021","unstructured":"Wei W, Lu M, Lan XB, Liu N, Su WK, Dushkin AV, et al. Neuroprotective effects of oxymatrine on PI3K\/Akt\/mTOR pathway after Hypoxic-Ischemic brain damage in neonatal rats. Front Pharmacol. 2021;12:642415.","journal-title":"Front Pharmacol"},{"issue":"6","key":"1452_CR26","doi-asserted-by":"publisher","first-page":"312","DOI":"10.4103\/ejpi.EJPI-D-24-00083","volume":"67","author":"Y Cheng","year":"2024","unstructured":"Cheng Y, Hussain SA, Alrubie TM, Zhang X. Neuroprotective role of transchalcone in parkinson\u2019s disease through AMP-activated protein Kinase-mediated signaling pathway. J Physiol Investig. 2024;67(6):312\u201320.","journal-title":"J Physiol Investig"},{"issue":"3","key":"1452_CR27","doi-asserted-by":"publisher","first-page":"129","DOI":"10.4103\/ejpi.EJPI-D-24-00006","volume":"67","author":"J Wang","year":"2024","unstructured":"Wang J, Hussain SA, Maddu N, Li H. Protective effects of Trans-Chalcone on myocardial ischemia and reperfusion challenge through targeting phosphoinositide 3-kinase\/Akt-inflammosome interaction. J Physiol Investig. 2024;67(3):129\u201338.","journal-title":"J Physiol Investig"},{"issue":"5","key":"1452_CR28","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1007\/s12035-020-02220-w","volume":"58","author":"IO Yusuf","year":"2021","unstructured":"Yusuf IO, Chen HM, Cheng PH, Chang CY, Tsai SJ, Chuang JI, et al. Fibroblast growth factor 9 stimulates neuronal length through NF-kB signaling in striatal cell huntington\u2019s disease models. Mol Neurobiol. 2021;58(5):2396\u2013406.","journal-title":"Mol Neurobiol"},{"issue":"3","key":"1452_CR29","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.gendis.2020.06.005","volume":"8","author":"MR Zinatizadeh","year":"2021","unstructured":"Zinatizadeh MR, Schock B, Chalbatani GM, Zarandi PK, Jalali SA, Miri SR. The nuclear factor kappa B (NF-kB) signaling in cancer development and immune diseases. Genes Dis. 2021;8(3):287\u201397.","journal-title":"Genes Dis"},{"issue":"31","key":"1452_CR30","doi-asserted-by":"publisher","first-page":"11023","DOI":"10.1073\/pnas.0504921102","volume":"102","author":"F Borovecki","year":"2005","unstructured":"Borovecki F, Lovrecic L, Zhou J, Jeong H, Then F, Rosas HD, et al. Genome-wide expression profiling of human blood reveals biomarkers for huntington\u2019s disease. Proc Natl Acad Sci U S A. 2005;102(31):11023\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"1452_CR31","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/j.celrep.2017.04.021","volume":"19","author":"RG Lim","year":"2017","unstructured":"Lim RG, Quan C, Reyes-Ortiz AM, Lutz SE, Kedaigle AJ, Gipson TA, et al. Huntington\u2019s disease iPSC-Derived brain microvascular endothelial cells reveal WNT-Mediated angiogenic and Blood-Brain barrier deficits. Cell Rep. 2017;19(7):1365\u201377.","journal-title":"Cell Rep"},{"key":"1452_CR32","doi-asserted-by":"publisher","first-page":"736","DOI":"10.3389\/fnins.2017.00736","volume":"11","author":"S Naphade","year":"2017","unstructured":"Naphade S, Embusch A, Madushani KL, Ring KL, Ellerby LM. Altered expression of matrix metalloproteinases and their endogenous inhibitors in a human isogenic stem cell model of huntington\u2019s disease. Front Neurosci. 2017;11:736.","journal-title":"Front Neurosci"},{"issue":"6","key":"1452_CR33","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.stemcr.2015.11.005","volume":"5","author":"KL Ring","year":"2015","unstructured":"Ring KL, An MC, Zhang N, O\u2019Brien RN, Ramos EM, Gao F, et al. Genomic analysis reveals disruption of striatal neuronal development and therapeutic targets in human huntington\u2019s disease neural stem cells. Stem Cell Rep. 2015;5(6):1023\u201338.","journal-title":"Stem Cell Rep"},{"issue":"6","key":"1452_CR34","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/j.theriogenology.2016.04.088","volume":"86","author":"PH Cheng","year":"2016","unstructured":"Cheng PH, Chang YF, Mao SH, Lin HL, Chen CM, Yang SH. Lentiviral transgenesis in mice via a simple method of viral concentration. Theriogenology. 2016;86(6):1427\u201335.","journal-title":"Theriogenology"},{"issue":"9","key":"1452_CR35","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.7150\/thno.18813","volume":"7","author":"LS Her","year":"2017","unstructured":"Her LS, Mao SH, Chang CY, Cheng PH, Chang YF, Yang HI, et al. miR-196a enhances neuronal morphology through suppressing RANBP10 to provide neuroprotection in huntington\u2019s disease. Theranostics. 2017;7(9):2452\u201362.","journal-title":"Theranostics"},{"key":"1452_CR36","doi-asserted-by":"publisher","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu T, Zhang L, Joo D, Sun SC. NF-kappaB signaling in inflammation. Signal Transduct Target Ther. 2017;2:17023.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"1452_CR37","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12974-018-1204-7","volume":"15","author":"Y Yang","year":"2018","unstructured":"Yang Y, Boza-Serrano A, Dunning CJR, Clausen BH, Lambertsen KL, Deierborg T. Inflammation leads to distinct populations of extracellular vesicles from microglia. J Neuroinflammation. 2018;15(1):168.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"1452_CR38","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/stem.2730","volume":"36","author":"MT Harting","year":"2018","unstructured":"Harting MT, Srivastava AK, Zhaorigetu S, Bair H, Prabhakara KS, Toledano Furman NE, et al. Inflammation-Stimulated mesenchymal stromal Cell-Derived extracellular vesicles attenuate inflammation. Stem Cells. 2018;36(1):79\u201390.","journal-title":"Stem Cells"},{"issue":"3","key":"1452_CR39","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","volume":"87","author":"L Mangiarini","year":"1996","unstructured":"Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in Transgenic mice. Cell. 1996;87(3):493\u2013506.","journal-title":"Cell"},{"issue":"2","key":"1452_CR40","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.brainresrev.2008.12.001","volume":"59","author":"JM Gil","year":"2009","unstructured":"Gil JM, Rego AC. The R6 lines of Transgenic mice: a model for screening new therapies for huntington\u2019s disease. Brain Res Rev. 2009;59(2):410\u201331.","journal-title":"Brain Res Rev"},{"issue":"6","key":"1452_CR41","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1111\/cns.14160","volume":"29","author":"GS Fitzgerald","year":"2023","unstructured":"Fitzgerald GS, Chuchta TG, McNay EC. Insulin-like growth factor-2 is a promising candidate for the treatment and prevention of alzheimer\u2019s disease. CNS Neurosci Ther. 2023;29(6):1449\u201369.","journal-title":"CNS Neurosci Ther"},{"key":"1452_CR42","doi-asserted-by":"crossref","unstructured":"Scalia P, Williams SJ, Fujita-Yamaguchi Y. Human IGF2 gene epigenetic and transcriptional regulation: at the core of developmental growth and tumorigenic behavior. Biomedicines. 2023;11(6).","DOI":"10.3390\/biomedicines11061655"},{"key":"1452_CR43","doi-asserted-by":"publisher","first-page":"0152","DOI":"10.34133\/bmr.0152","volume":"29","author":"GH Cho","year":"2025","unstructured":"Cho GH, Bae HC, Lee YJ, Yang HR, Kang H, Park HJ, et al. Insulin-Like growth factor 2 secreted from mesenchymal stem cells with high glutathione levels alleviates osteoarthritis via paracrine rejuvenation of senescent chondrocytes. Biomater Res. 2025;29:0152.","journal-title":"Biomater Res"},{"key":"1452_CR44","doi-asserted-by":"publisher","first-page":"9390611","DOI":"10.1155\/2022\/9390611","volume":"2022","author":"H Zhan","year":"2022","unstructured":"Zhan H, Xiao J, Wang P, Mo F, Li K, Guo F, et al. Exosomal CTCF confers cisplatin resistance in osteosarcoma by promoting autophagy via the IGF2-AS\/miR-579-3p\/MSH6 Axis. J Oncol. 2022;2022:9390611.","journal-title":"J Oncol"}],"container-title":["Cell &amp; Bioscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13578-025-01452-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13578-025-01452-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13578-025-01452-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T10:09:46Z","timestamp":1781604586000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13578-025-01452-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,26]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1452"],"URL":"https:\/\/doi.org\/10.1186\/s13578-025-01452-4","relation":{},"ISSN":["2045-3701"],"issn-type":[{"value":"2045-3701","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,26]]},"assertion":[{"value":"10 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read the manuscript, and agree with the consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"109"}}